Role of urologists in the era of new treatment modalities for CRPC in Japan - Abstract

New medical treatment modalities for castration resistant prostate cancer(CRPC), including hormonal therapy and chemotherapy, will be approved in Japan.

Here, we discuss the management of these new treatment strategies by urologists.

Written by:
Ozono S.   Are you the author?
Dept. of Urology, Hamamatsu University School of Medicine.

Reference: Gan To Kagaku Ryoho. 2014 Jul;41(7):823-6.

PubMed Abstract
PMID: 25131867

Article in Japanese. Prostate Cancer Section